$东阳光长江药业(0_老虎社区_美港股上老虎

$东阳光长江药业(01558)$ 东阳光药目前在流感领域布局新药物，儿童抗感染领域将关注肺炎支原体、抗生素、合胞病毒和鼻炎等细分市场。在销售综合策略下，预计3-5年内形成200亿以上销售额。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":325176362950904,"tweetId":"325176362950904","gmtCreate":1720417962430,"gmtModify":1720417963942,"author":{"id":4107239966895660,"authorId":4107239966895660,"authorIdStr":"4107239966895660","name":"小胖子kon","avatar":"https://static.tigerbbs.com/6246e486a2b266876dd2e5068793e479","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>东阳光药目前在流感领域布局新药物，儿童抗感染领域将关注肺炎支原体、抗生素、合胞病毒和鼻炎等细分市场。在销售综合策略下，预计3-5年内形成200亿以上销售额。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01558\">$东阳光长江药业(01558)$ &nbsp;</a>东阳光药目前在流感领域布局新药物，儿童抗感染领域将关注肺炎支原体、抗生素、合胞病毒和鼻炎等细分市场。在销售综合策略下，预计3-5年内形成200亿以上销售额。</p></body></html>","text":"$东阳光长江药业(01558)$ 东阳光药目前在流感领域布局新药物，儿童抗感染领域将关注肺炎支原体、抗生素、合胞病毒和鼻炎等细分市场。在销售综合策略下，预计3-5年内形成200亿以上销售额。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/325176362950904","repostId":0,"isVote":1,"tweetType":1,"viewCount":106,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01558"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":167,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/325176362950904"}